Roche Holding AG
OTC:RHHBF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Roche Holding AG
OTC:RHHBF
|
CH |
Intrinsic Value
The intrinsic value of Roche Holding AG (RHHBF) under the Base Case is 408.02 USD per share.
Compared with the current market price of 460 USD, the stock appears
Overvalued by 11% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Roche Does
Roche Holding AG is a Swiss healthcare company that makes prescription medicines and diagnostic tests. Its drug business focuses on treatments in cancer, immunology, ophthalmology, and other serious diseases, while its diagnostics business sells instruments, lab tests, and software that help hospitals and laboratories detect disease and monitor patients. In simple terms, Roche helps doctors find illnesses and choose treatments, and it earns money by selling these medicines, test kits, and related systems to healthcare providers and distributors.
- Headquarters
- Switzerland CH
- Employees
- 100 920
- IPO date
- May 4, 2001
Earnings Waterfall
Roche Holding AG
The intrinsic value for Roche Holding AG (RHHBF) under the Base Case is 408.02 USD.
Compared with the current market price of 460 USD, the stock appears Overvalued by 11% .